Literature DB >> 11417665

Which symptoms of anxiety diminish after surgical interventions for Parkinson disease?

C I Higginson1, J A Fields, A I Tröster.   

Abstract

OBJECTIVE: The purpose of the current study was to address whether improvement in anxious symptoms after surgical treatment of Parkinson disease (PD) reflects a true reduction in anxiety as opposed to an epiphenomenon of parkinsonian symptom amelioration.
BACKGROUND: Recent research suggests that anxiety is common in PD. An association between surgical intervention for PD and anxiety reduction has been reported; however, it is not clear which specific symptoms of anxiety improve.
METHOD: Thirty-nine PD patients completed the Beck Anxiety Inventory (BAI) approximately 1 month before and 4 months after surgery. Twenty-four participants underwent unilateral pallidotomy, 10 underwent deep brain stimulating electrode implantation of the internal segment of the globus pallidus, 4 underwent thalamic deep brain stimulating electrode implantation, and 1 underwent left thalamotomy.
RESULTS: Statistically significant reductions were found postoperatively in terms of BAI total score as well as neurophysiologic, autonomic, and subjective factors from the BAI. The panic factor did not significantly change after surgery, possibly secondary to limited power afforded by the sample size.
CONCLUSIONS: Results suggest that surgical intervention for PD is associated with reduction in anxiety symptoms distinct from symptoms of PD. In other words, improvement in anxious symptoms reflects a true reduction in anxiety rather than simply being an epiphenomenon of parkinsonian symptom amelioration.

Entities:  

Mesh:

Year:  2001        PMID: 11417665

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  11 in total

1.  Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor.

Authors:  J A Fields; A I Tröster; S P Woods; C I Higginson; S B Wilkinson; K E Lyons; W C Koller; R Pahwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

Review 2.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

3.  The relation of anxiety and cognition in Parkinson's disease.

Authors:  Gretchen O Reynolds; Kristine K Hanna; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychology       Date:  2017-04-20       Impact factor: 3.295

Review 4.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

Review 5.  Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review.

Authors:  Steven Paul Woods; Julie A Fields; Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2002-06       Impact factor: 7.444

Review 6.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

7.  Neuropsychiatric symptoms three years after subthalamic DBS in PD patients: a case-control study.

Authors:  Lorys Castelli; Maurizio Zibetti; Laura Rizzi; Marcella Caglio; Michele Lanotte; Leonardo Lopiano
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

Review 8.  ["Psychosurgery" and deep brain stimulation with psychiatric indication. Current and historical aspects].

Authors:  M Arends; H Fangerau; G Winterer
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

9.  Anxiety in Parkinson's Disease: Correlation with Depression and Quality of Life.

Authors:  Ankush Upneja; Birinder S Paul; Dinesh Jain; Rupesh Choudhary; Gunchan Paul
Journal:  J Neurosci Rural Pract       Date:  2021-03-24

10.  VBM Reveals Brain Volume Differences between Parkinson's Disease and Essential Tremor Patients.

Authors:  Ching-Hung Lin; Chun-Ming Chen; Ming-Kuei Lu; Chon-Haw Tsai; Jin-Chern Chiou; Jan-Ray Liao; Jeng-Ren Duann
Journal:  Front Hum Neurosci       Date:  2013-06-14       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.